Effects of canagliflozin in patients with baseline eGFR<30 ml/min per 1.73 m2: Subgroup analysis of the randomized CREDENCE trial
Clinical Journal of the American Society of Nephrology | Dec 10, 2020
Ziltivekimab for treatment of anemia of inflammation in patients on hemodialysis: Results from a phase 1/2 multicenter, randomized, double-blind, placebo-controlled trial
Journal of the American Society of Nephrology | Dec 08, 2020
Uric acid to high-density lipoprotein cholesterol ratio predicts cardiovascular mortality in patients on peritoneal dialysis
Nutrition, Metabolism & Cardiovascular Diseases | Oct 19, 2020
Most read this week